Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain

By Jelena Martinovic
April 23, 10:24 AM
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration (FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move, the company initiated the regulatory process with the FDA for the approval of its prolonged CBD release technology for human use.

CSE:INNO

Read More
2 minute read

CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval

By Jelena Martinovic
February 13, 4:22 PM
Cannabinoid-focused pharmaceutical company Innocan Pharma Corp expects preliminary revenues of $4.89m in Q4 of fiscal 2023, representing a YoY increase of 331%. It said preliminary revenues are expected to be at least $13.6m for the whole of the fiscal year, a 433% YoY increase. Its subsidiary B.I. Sky Global drove the increase in sales. Innocan is currently pursuing FDA approval for its human pharmaceutical applications following successful pre-clinical trials, and the company expects pre-investigational new drug applications to be submitted to the FDA before the end of the month. Innocan has developed a long-lasting and therapeutic liposomal formulation for CBD called LPT Solution, which administers injectable CBD encapsulated in liposomes to achieve long-lasting therapeutic levels of CBD in the body. The company said the technology creates a more effective and prolonged therapeutic effect. Innocan plans to test the LPT platform on a new animal species in the near future.

CSE:INNO

Read More
4 minute read

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024

By Jelena Martinovic
December 22, 5:31 PM
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and Indigenous-led cannabis organizations across the United States to discuss community-oriented approaches to hemp and cannabis regulation. The event was part of the association's annual National Indigenous Cannabis Policy Summit, which aims to promote economic benefits and professional development for Indigenous communities through responsible, community-oriented planning around cannabis. Meanwhile, trade show and media company Emerald Holding has promoted Emilie Lewis to senior vice president, where she will oversee marketing, audience, and content strategy for Marijuana Business Daily. The move comes following the departure of former MJBiz senior vice president Pam Moore. Additionally, several cannabis companies have reported board shake-ups, while Trulieve Cannabis and Organigram Holdings have named new chief financial officers.

CSE:INNO